StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
10
Publishing Date
2023 - 10 - 16
1
2023 - 02 - 27
1
2022 - 12 - 22
1
2022 - 12 - 01
1
2021 - 11 - 17
1
2021 - 06 - 22
1
2021 - 06 - 10
1
2021 - 05 - 11
1
2021 - 05 - 04
1
2021 - 04 - 01
1
Sector
Health technology
10
Manufacturing
1
Tags
Active
2
Antibody
1
Application
1
Approval
1
Asia
1
Authorized
1
Cancer
2
Candidate
1
Children
1
Collaboration
1
Covid
2
Covid-19
1
Disease
1
Drug
2
Drug delivery
1
Ema
1
Europe
1
Fda
2
Food
1
Germany
1
Hiv
1
Hormone
1
License
1
Liver
1
Living
1
Market
1
Merge
1
N/a
8
News
1
Prostate cancer
1
Report
1
Research
1
Results
1
Review
1
Technology
1
Treatment
2
Trial
1
Ulcerative colitis
1
Vaccine
3
Valneva
1
Entities
Abb ltd
32
Abbott laboratories
32
Abbvie inc.
25
Accenture plc
26
Adobe inc.
21
Advantest corp
17
Alphabet inc.
37
Alstom
41
Apple inc.
25
Arrival
119
Ase technology holding co., ltd.
27
Astellas pharma inc
21
Astrazeneca plc
18
Autoliv, inc.
19
Blackrock, inc.
36
Bnp paribas
208
Borr drilling limited
21
Broadcom inc.
30
Broadridge financial solutions, inc.
21
Caledonia mining corporation plc
54
Celyad sa
20
Clarivate plc
37
Dell technologies inc.
17
Elbit systems ltd.
49
Equinor asa
77
Ericsson
56
Flex lng ltd.
39
Glaxosmithkline plc
18
Honeywell international inc.
40
Idex biometrics asa - adr
23
Infineon technologies ag
18
Innate pharma s.a.
22
Innate pharma sa
21
Johnson & johnson
69
Johnson controls international plc
19
Kbc group nv
27
Kering
28
Koninklijke philips nv
28
Mainz biomed b.v.
16
Medtronic plc
27
Morgan stanley
56
Nidec corp
25
Nokia corp
20
Novartis ag
39
Novo nordisk a/s
36
Orange
94
Pearson plc
18
Relief therapeutics holding sa
17
Relx plc
19
Sanofi
149
Sap se
43
Seiko epson corp
20
Sony group corp
19
Stellantis n.v
28
Teva pharmaceutical industries ltd
16
Thermo fisher scientific inc
25
Unilever plc
18
Vaalco energy, inc.
25
Veon ltd.
28
Verona pharma plc
30
Symbols
ABBV
1
AERI
1
BNTX
2
CYDY
1
GSK
1
HALO
1
LGND
1
NVS
1
NVSEF
1
PFE
10
SNY
2
TEVJF
1
Exchanges
Nasdaq
6
Nyse
10
Crawled Date
2023 - 10 - 16
1
2023 - 02 - 27
1
2022 - 12 - 22
1
2022 - 12 - 01
1
2021 - 11 - 17
1
2021 - 06 - 22
1
2021 - 06 - 10
1
2021 - 05 - 11
1
2021 - 05 - 04
1
2021 - 04 - 01
1
Crawled Time
00:00
25
00:01
1
00:20
4
01:00
15
02:00
6
03:00
1
04:00
4
04:20
1
05:00
9
05:03
1
05:10
1
06:00
8
06:03
2
07:00
10
08:00
3
08:20
3
09:00
11
09:01
1
10:00
16
10:51
1
11:00
66
11:01
1
12:00
90
12:03
1
12:15
4
12:20
16
12:30
12
12:34
1
13:00
45
13:01
1
13:07
1
13:14
1
13:15
3
13:17
1
13:20
6
13:27
1
13:30
6
13:50
1
13:55
1
14:00
38
14:03
1
14:15
2
14:20
5
14:30
1
15:00
34
15:15
3
15:20
9
15:21
1
15:28
1
15:30
4
16:00
39
16:20
2
17:00
27
18:00
23
18:31
2
19:00
20
20:00
17
21:00
27
22:00
26
23:00
14
Source
www.4dpharmaplc.com
1
www.biospace.com
2
www.globenewswire.com
4
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Pfizer, inc.
crawled time :
07:00
save search
Everest Medicines' Licensing Partner Pfizer Announces U.S. FDA Approves Etrasimod for Adults with Moderately to Severely Active Ulcerative Colitis
Published:
2023-10-16
(Crawled : 07:00)
- biospace.com/
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-20.83%
|
O:
2.24%
H:
3.32%
C:
1.34%
fda
active
Optic Nerve Disorder Treatment Market to Reach USD 5.3 Billion, Globally, by 2031 at 4.5% CAGR: Allied Market Research
Published:
2023-02-27
(Crawled : 07:00)
- prnewswire.com
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-39.11%
|
O:
-0.74%
H:
0.7%
C:
-1.59%
NVS
|
News
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
8.71%
|
O:
0.64%
H:
0.01%
C:
-0.72%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
7.34%
|
O:
0.36%
H:
0.97%
C:
0.67%
treatment
research
market
Everest Medicines' Licensing Partner Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis Everest Medicines announced that its licensing partner, Pfizer Inc. has received acceptance from the U.S. Food and Drug Administration for review a New Drug Application for etrasimod for individuals living with moderately-to-severely active ulcerative colitis.
Published:
2022-12-22
(Crawled : 07:00)
- biospace.com/
CYDY
|
$0.148
0.06%
1.5M
|
Manufacturing
|
-29.49%
|
O:
-4.34%
H:
0.35%
C:
-5.13%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-50.79%
|
O:
-0.48%
H:
0.56%
C:
0.45%
fda
drug
active
ema
application
review
food
living
ulcerative colitis
Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults for Lyme Disease Vaccine Candidate
Published:
2022-12-01
(Crawled : 07:00)
- globenewswire.com
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-49.29%
|
O:
0.36%
H:
1.68%
C:
1.53%
valneva
candidate
disease
report
antibody
children
vaccine
Imugene Announces Clinical Trial Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate HER-Vaxx in Combination with Avelumab for Treatment of Gastric Cancer
Published:
2021-11-17
(Crawled : 07:00)
- globenewswire.com
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-48.6%
|
O:
0.95%
H:
0.0%
C:
0.0%
treatment
germany
cancer
trial
ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE® drug delivery technology to enable development of "ultra-long-acting" medicines for HIV
Published:
2021-06-22
(Crawled : 07:00)
- prnewswire.com
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-35.51%
|
O:
-0.03%
H:
0.71%
C:
0.51%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
-0.45%
|
O:
-0.7%
H:
0.05%
C:
-1.06%
HALO
M
|
$38.02
-0.94%
-0.95%
700K
|
Health Technology
|
-9.84%
|
O:
0.19%
H:
2.15%
C:
1.89%
collaboration
drug
license
technology
drug delivery
liver
hiv
Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations
Published:
2021-06-10
(Crawled : 07:00)
- globenewswire.com
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-36.15%
|
O:
0.23%
H:
2.06%
C:
1.95%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-12.64%
|
O:
1.21%
H:
1.07%
C:
0.67%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-64.25%
|
O:
-0.62%
H:
3.19%
C:
-0.08%
covid
vaccine
Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
Published:
2021-05-11
(Crawled : 07:00)
- globenewswire.com
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-36.23%
|
O:
-0.45%
H:
0.98%
C:
-0.83%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-12.09%
|
O:
-1.47%
H:
0.7%
C:
0.52%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-57.33%
|
O:
-7.78%
H:
8.52%
C:
6.11%
covid
vaccine
merge
authorized
covid-19
Astellas' XTANDI™ (enzalutamide) Approved by European Commission for Men with Metastatic Hormone-Sensitive Prostate Cancer
Published:
2021-05-04
(Crawled : 07:00)
- prnewswire.com
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-36.18%
|
O:
0.43%
H:
0.43%
C:
-0.13%
europe
prostate cancer
cancer
hormone
approval
Final Results for the year ended 31 December 2020
Published:
2021-04-01
(Crawled : 07:00)
- 4dpharmaplc.com
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-29.84%
|
O:
0.19%
H:
0.41%
C:
0.0%
LGND
|
News
|
$78.93
-1.24%
-1.25%
180K
|
Health Technology
|
-48.27%
|
O:
1.21%
H:
1.62%
C:
0.2%
results
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.